Developer docs
API playgroundTry for free, no card

Search company profiles

Bioveta

Full company profile

uuid0009iru

Namestring
Bioveta
Legal namestring
Bioveta a.s.
Websiteurl
bioveta.cz
Company typeenum
Private
Founded yearint
1918
Descriptiontext

Bioveta a.s. is a privately held Czech veterinary pharmaceutical company headquartered in Ivanovice na Hané. Founded in 1918, it develops, manufactures, and distributes a broad portfolio of veterinary medicinal products for both production animals (cattle, pigs, poultry, sheep, goats) and companion animals (dogs, cats, horses, rabbits). The integrated manufacturing footprint is anchored at a single site in the Czech Republic, and products are exported to more than 90 countries through localized websites in eight languages (Czech, English, Slovak, Polish, Romanian, Russian, Turkish, Ukrainian), a wholly-owned Russian subsidiary (Bioveta Rusko), and channel partners including Lekoom AD in Bulgaria and Salfarm in Denmark.

The product portfolio spans vaccines (BioBos BTV multi-serotype line for bluetongue, BioBos IBR Marker, Trichoben for cattle ringworm with at least five-year immunity, Kolibin RC Neo for neonatal calf enteric infections, Biocan Novel for companion animals), pharmaceutical preparations (Jodouter intrauterine povidone-iodine solution, Amoxicillin Bioveta LA), antiparasitics (Fipron spot-on, Top Spot On, Bio Kill, MIZIVERM), dermatologicals (BioDexin, Otipur, Alaptid ointment), nutraceuticals (ATLET BS, ATLET MSM, ATLET Syrup, ATLET ProDrink), and diagnostics. Differentiation rests on cattle-vaccine R&D (e.g., 5-year Trichoben immunity, colostral passive protection via Kolibin RC Neo) and a diversified multi-species offering rather than on any platform technology.

Bioveta generates revenue primarily through one-time sales of its veterinary medicines to distributors, veterinary clinics, and animal-shelter/CSR channels internationally, with a direct-to-consumer e-commerce storefront (biovetapets.cz) for pet products in the Czech Republic. Go-to-market is channel-partner and event-driven: heavy participation in veterinary trade shows (EuroTier, IPPE, VIV Asia, ESPHM, VIV MEA, VetME Dubai), co-hosted workshops and seminars with regional distributors, a quarterly corporate publication (Bioveta News since 2008), and social channels (Facebook, Instagram). Pricing is not publicly disclosed; the company is described as a private joint-stock company with no identified external shareholders or funding rounds.

Short descriptiontext

Bioveta a.s. is a Czech veterinary pharmaceutical company, founded in 1918, that develops, manufactures, and distributes vaccines, pharmaceuticals, antiparasitics, and nutraceuticals for livestock and companion animals, exporting to more than 90 countries through international distribution partners, a Russian subsidiary, and a Czech e-commerce storefront.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersIvanovice Na Hané, Czechia
HQ citystring
Ivanovice Na Hané
HQ countrystring
Czechia
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary pharmaceuticals, animal vaccines, livestock health products, companion animal care, veterinary medicines
Industry4 codes
PRIMARYHLAMAEAL
Veterinary Vaccines (Biologics)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAB
Livestock & Production Animal Therapeutics (Rx)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAE
Antimicrobials & Anti-infectives
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAIAEAH
Veterinary Vaccines
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Pharmaceutical Preparation Manufacturing325412
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Pharmaceutical Preparations2834
Product category
Veterinary Pharmaceuticals
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Veterinary Pharmaceuticals
TypeOne Time License
Description

Sale of veterinary medicinal products including vaccines, antibiotics, antiparasitics, dermatological products, hormones, and diagnostic products for livestock and companion animals.

bioveta.cz
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Biocan Novel
Description

A new line of vaccines presented at VRVC Thailand 2017 for registration in Thailand and Philippines

bioveta.cz
+3 more records
Core offering1 text field

Bioveta is a Czech veterinary pharmaceutical company that manufactures veterinary medicinal products using modern technologies. Its portfolio covers vaccines (inactivated and live attenuated), injectable solutions, intrauterine preparations, topical products, antiparasitics, dermatological products, hormonal treatments, nutraceuticals, and diagnostic products for livestock (cattle, pigs, poultry, sheep, goats) and companion animals (dogs, cats, horses, rabbits). The company exports to more than 90 countries worldwide and has been in continuous operation since 1918.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Bioveta a.s. is a Czech veterinary pharmaceutical company manufacturing veterinary medicinal products using modern technologies. The product portfolio includes vaccines (KOLIBIN RC NEO, TRICHOBEN, BioBos BTV line for bluetongue, BioBos IBR Marker, Biocan Novel), pharmaceutical preparations (JODOUTER intrauterine solution, AMOXICILLIN BIOVETA LA), dermatological products (ALAPTID ointment, BIODEXIN, OTIPUR), antiparasitics (FIPRON, TOP SPOT ON, BIO KILL), joint nutrition supplements (ATLET BS, ATLET MSM, ATLET Syrup), vitamins (ADE-VIT), and diagnostic products (AVITUBAL). The company exports to more than 90 countries worldwide and publishes the Bioveta News magazine for veterinary professionals.

Product and service1 record
1KOLIBIN RC NEO
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Ukrainian Association of Small Animal Veterinary Medicine (USAVA-VNAU)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-05-28
Description

Bioveta was a partner of the Ukrainian online veterinary congress USAVA-VNAU 2020, featuring international speakers including Dr. Jiří Neužil (Regional Director for Ukraine) presenting on immunology and vaccination trends, and Professor Miroslav Svoboda presenting on dermatology.

2Bioveta Rusko (Bioveta Russia)
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2018-01-30
Description

Russian subsidiary that represents Bioveta at international exhibitions in Russia including MVC: Cereals - Mixed Feed - Veterinary trade show in Moscow. The subsidiary handles distribution and representation in the Russian market.

3Lekoom AD
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2017-10-27
Description

Bulgarian company Lekoom AD is the largest distributor of Bioveta products in Bulgaria. The companies co-organize educational seminars for Bulgarian veterinarians on topics including dermatology and immunology of dogs and cats. Lekoom distributes the full range of Bioveta products including vaccines, antiparasitics, and other veterinary preparations.

bioveta.cz
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2017-05-05
Description

Danish partner company with whom Bioveta co-exhibited at the 9th European Symposium of Porcine Health Management (ESPHM) in Prague in May 2017. Salfarm serves as Bioveta's distribution partner in Denmark.

5Psí hvězda Foundation
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Bioveta, together with the Psí hvězda Foundation, provided combined vaccines to protect dogs from the Kamenice puppy mill case. Vaccines were delivered to veterinarians providing care at animal shelters including Dejte nám šanci, Russell Rescue, Dočasky.cz, Záchranné depozitum pro psy Beruška, and Azyl Dej Pac.

bioveta.cz
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large global animal health company with a broad portfolio across livestock and companion animals; competes with Bioveta across multiple therapeutic categories but at much greater scale.

TypeDirect peer
Description

Mid-size animal health company focused on livestock pharmaceuticals, vaccines, and nutrition specialties — directly comparable mid-cap veterinary pharma business with similar species emphasis and product breadth.

TypeDirect peer
Description

German veterinary biologics manufacturer with deep expertise in livestock vaccines (BTV, IBR) and contract manufacturing; competes most directly with Bioveta's inactivated-vaccine portfolio in the European bluetongue market.

TypeDirect peer
Description

Mid-size French veterinary pharmaceutical group focused exclusively on animal health with a comparable product mix (vaccines, antiparasitics, dermatology, supplements) and a similar private/independent ownership profile; closest analog to Bioveta in size and strategy.

TypeDirect peer
Description

Independent French veterinary pharmaceutical company of similar mid-cap scale, manufacturing vaccines and therapeutics for livestock and companion animals; directly comparable specialty animal-health peer.

TypeDirect peer
Description

Bulgarian-headquartered animal health and nutrition company producing veterinary pharmaceuticals, vaccines, and feed additives; a regional peer with a similar Eastern European manufacturing base and CEE market presence.

TypeDirect peer
Description

Privately held French veterinary pharmaceutical company specializing in vaccines, reproduction, and livestock pharmaceuticals — directly comparable portfolio emphasis and ownership structure to Bioveta.

TypeBroad incumbent
Description

Division of Merck offering veterinary vaccines, antiparasitics, and pharmaceuticals across species — overlapping product categories (BTV, IBR, companion animal vaccines) with Bioveta and a much larger global footprint.

TypeBroad incumbent
Description

Global leader in animal health and veterinary pharmaceuticals with a comprehensive vaccine and therapeutics portfolio across livestock and companion animals — directly comparable value chain but significantly larger scale and R&D budget than Bioveta.

10Boehringer Ingelheim Animal Health
TypeBroad incumbent
Description

Major veterinary vaccines and pharmaceuticals player with strengths in livestock and companion animal biologics; competes with Bioveta in the same veterinary biologics and pharmaceutical preparation categories globally.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bioveta

Veterinary Pharmaceuticalsbioveta.cz

Bioveta a.s. is a Czech veterinary pharmaceutical company, founded in 1918, that develops, manufactures, and distributes vaccines, pharmaceuticals, antiparasitics, and nutraceuticals for livestock and companion animals, exporting to more than 90 countries through international distribution partners, a Russian subsidiary, and a Czech e-commerce storefront.

What Bioveta does

Bioveta a.s. is a privately held Czech veterinary pharmaceutical company headquartered in Ivanovice na Hané. Founded in 1918, it develops, manufactures, and distributes a broad portfolio of veterinary medicinal products for both production animals (cattle, pigs, poultry, sheep, goats) and companion animals (dogs, cats, horses, rabbits). The integrated manufacturing footprint is anchored at a single site in the Czech Republic, and products are exported to more than 90 countries through localized websites in eight languages (Czech, English, Slovak, Polish, Romanian, Russian, Turkish, Ukrainian), a wholly-owned Russian subsidiary (Bioveta Rusko), and channel partners including Lekoom AD in Bulgaria and Salfarm in Denmark.

The product portfolio spans vaccines (BioBos BTV multi-serotype line for bluetongue, BioBos IBR Marker, Trichoben for cattle ringworm with at least five-year immunity, Kolibin RC Neo for neonatal calf enteric infections, Biocan Novel for companion animals), pharmaceutical preparations (Jodouter intrauterine povidone-iodine solution, Amoxicillin Bioveta LA), antiparasitics (Fipron spot-on, Top Spot On, Bio Kill, MIZIVERM), dermatologicals (BioDexin, Otipur, Alaptid ointment), nutraceuticals (ATLET BS, ATLET MSM, ATLET Syrup, ATLET ProDrink), and diagnostics. Differentiation rests on cattle-vaccine R&D (e.g., 5-year Trichoben immunity, colostral passive protection via Kolibin RC Neo) and a diversified multi-species offering rather than on any platform technology.

Bioveta generates revenue primarily through one-time sales of its veterinary medicines to distributors, veterinary clinics, and animal-shelter/CSR channels internationally, with a direct-to-consumer e-commerce storefront (biovetapets.cz) for pet products in the Czech Republic. Go-to-market is channel-partner and event-driven: heavy participation in veterinary trade shows (EuroTier, IPPE, VIV Asia, ESPHM, VIV MEA, VetME Dubai), co-hosted workshops and seminars with regional distributors, a quarterly corporate publication (Bioveta News since 2008), and social channels (Facebook, Instagram). Pricing is not publicly disclosed; the company is described as a private joint-stock company with no identified external shareholders or funding rounds.

Bioveta firmographics

Firmographics
Name
Bioveta
Legal name
Bioveta a.s.
Website
https://bioveta.cz
Company type
Private
Founded year
1918
Operating status
Operating
Headcount range
11–50 employees
Short description
Bioveta a.s. is a Czech veterinary pharmaceutical company, founded in 1918, that develops, manufactures, and distributes vaccines, pharmaceuticals, antiparasitics, and nutraceuticals for livestock and companion animals, exporting to more than 90 countries through international distribution partners, a Russian subsidiary, and a Czech e-commerce storefront.
Ownership category
akta.pro rank

Bioveta industry classification

Industry
Product category
Veterinary Pharmaceuticals
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412)
SIC
Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAMAEAL
Veterinary Vaccines (Biologics)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAB
Livestock & Production Animal Therapeutics (Rx)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAE
Antimicrobials & Anti-infectives
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAIAEAH
Veterinary Vaccines

Keywords

  • Veterinary pharmaceuticals
  • Animal vaccines
  • Livestock health products
  • Companion animal care
  • Veterinary medicines

Where Bioveta is headquartered

Location

Headquarters

HQ city
Ivanovice Na Hané
HQ country
Czechia
HQ region
Europe

Offices1 record

Markets served

Bioveta business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Veterinary Pharmaceuticals: Sale of veterinary medicinal products including vaccines, antibiotics, antiparasitics, dermatological products, hormones, and diagnostic products for livestock and companion animals.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Bioveta product offering

Product offering

Core offering

Bioveta is a Czech veterinary pharmaceutical company that manufactures veterinary medicinal products using modern technologies. Its portfolio covers vaccines (inactivated and live attenuated), injectable solutions, intrauterine preparations, topical products, antiparasitics, dermatological products, hormonal treatments, nutraceuticals, and diagnostic products for livestock (cattle, pigs, poultry, sheep, goats) and companion animals (dogs, cats, horses, rabbits). The company exports to more than 90 countries worldwide and has been in continuous operation since 1918.

Product overview

Bioveta a.s. is a Czech veterinary pharmaceutical company manufacturing veterinary medicinal products using modern technologies. The product portfolio includes vaccines (KOLIBIN RC NEO, TRICHOBEN, BioBos BTV line for bluetongue, BioBos IBR Marker, Biocan Novel), pharmaceutical preparations (JODOUTER intrauterine solution, AMOXICILLIN BIOVETA LA), dermatological products (ALAPTID ointment, BIODEXIN, OTIPUR), antiparasitics (FIPRON, TOP SPOT ON, BIO KILL), joint nutrition supplements (ATLET BS, ATLET MSM, ATLET Syrup), vitamins (ADE-VIT), and diagnostic products (AVITUBAL). The company exports to more than 90 countries worldwide and publishes the Bioveta News magazine for veterinary professionals.

Differentiator

Problem solved

Functional benefit

Brands

  • Biocan Novel: A new line of vaccines presented at VRVC Thailand 2017 for registration in Thailand and Philippines
  • BioBos
  • ATLET
  • Bioveta News

Products and services

  • KOLIBIN RC NEO

Companies that use Bioveta

Customer profile

Segments3 records

Ideal customer profiles3 records

Bioveta technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Bioveta partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered minor, core and major.

  • Ukrainian Association of Small Animal Veterinary Medicine (USAVA-VNAU)minorStrategic or Co-development Partner · 28 May 2020Bioveta was a partner of the Ukrainian online veterinary congress USAVA-VNAU 2020, featuring international speakers including Dr. Jiří Neužil (Regional Director for Ukraine) presenting on immunology and vaccination trends, and Professor Miroslav Svoboda presenting on dermatology.
  • Bioveta Rusko (Bioveta Russia)coreChannel Partner/ Reseller/ Distributor · 30 January 2018Russian subsidiary that represents Bioveta at international exhibitions in Russia including MVC: Cereals - Mixed Feed - Veterinary trade show in Moscow. The subsidiary handles distribution and representation in the Russian market.
  • Lekoom ADmajorChannel Partner/ Reseller/ Distributor · 27 October 2017Bulgarian company Lekoom AD is the largest distributor of Bioveta products in Bulgaria. The companies co-organize educational seminars for Bulgarian veterinarians on topics including dermatology and immunology of dogs and cats. Lekoom distributes the full range of Bioveta products including vaccines, antiparasitics, and other veterinary preparations.
  • SalfarmminorChannel Partner/ Reseller/ Distributor · 5 May 2017Danish partner company with whom Bioveta co-exhibited at the 9th European Symposium of Porcine Health Management (ESPHM) in Prague in May 2017. Salfarm serves as Bioveta's distribution partner in Denmark.
  • Psí hvězda FoundationminorStrategic or Co-development PartnerBioveta, together with the Psí hvězda Foundation, provided combined vaccines to protect dogs from the Kamenice puppy mill case. Vaccines were delivered to veterinarians providing care at animal shelters including Dejte nám šanci, Russell Rescue, Dočasky.cz, Záchranné depozitum pro psy Beruška, and Azyl Dej Pac.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Bioveta competitors and assessment

Company assessment

Broad incumbents

  • Elanco Animal Health: Large global animal health company with a broad portfolio across livestock and companion animals; competes with Bioveta across multiple therapeutic categories but at much greater scale.
  • MSD Animal Health: Division of Merck offering veterinary vaccines, antiparasitics, and pharmaceuticals across species — overlapping product categories (BTV, IBR, companion animal vaccines) with Bioveta and a much larger global footprint.
  • Zoetis: Global leader in animal health and veterinary pharmaceuticals with a comprehensive vaccine and therapeutics portfolio across livestock and companion animals — directly comparable value chain but significantly larger scale and R&D budget than Bioveta.
  • Boehringer Ingelheim Animal Health: Major veterinary vaccines and pharmaceuticals player with strengths in livestock and companion animal biologics; competes with Bioveta in the same veterinary biologics and pharmaceutical preparation categories globally.

Direct peers

  • Phibro Animal Health: Mid-size animal health company focused on livestock pharmaceuticals, vaccines, and nutrition specialties — directly comparable mid-cap veterinary pharma business with similar species emphasis and product breadth.
  • IDT Biologika: German veterinary biologics manufacturer with deep expertise in livestock vaccines (BTV, IBR) and contract manufacturing; competes most directly with Bioveta's inactivated-vaccine portfolio in the European bluetongue market.
  • Virbac: Mid-size French veterinary pharmaceutical group focused exclusively on animal health with a comparable product mix (vaccines, antiparasitics, dermatology, supplements) and a similar private/independent ownership profile; closest analog to Bioveta in size and strategy.
  • Vetoquinol: Independent French veterinary pharmaceutical company of similar mid-cap scale, manufacturing vaccines and therapeutics for livestock and companion animals; directly comparable specialty animal-health peer.
  • Huvepharma: Bulgarian-headquartered animal health and nutrition company producing veterinary pharmaceuticals, vaccines, and feed additives; a regional peer with a similar Eastern European manufacturing base and CEE market presence.
  • Ceva Santé Animale: Privately held French veterinary pharmaceutical company specializing in vaccines, reproduction, and livestock pharmaceuticals — directly comparable portfolio emphasis and ownership structure to Bioveta.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Bioveta social profiles

Digital presence

Bioveta financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bioveta leadership team

Management profile

Number of profiles

Profiles3 records

Bioveta subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Bioveta funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bioveta M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioveta

What does Bioveta do?

Bioveta is a Czech veterinary pharmaceutical company that manufactures veterinary medicinal products using modern technologies. Its portfolio covers vaccines (inactivated and live attenuated), injectable solutions, intrauterine preparations, topical products, antiparasitics, dermatological products, hormonal treatments, nutraceuticals, and diagnostic products for livestock (cattle, pigs, poultry, sheep, goats) and companion animals (dogs, cats, horses, rabbits). The company exports to more than 90 countries worldwide and has been in continuous operation since 1918.

Is Bioveta a public or private company?

Bioveta is a private company. It is classified as unknown and is currently operating.

When was Bioveta founded?

Bioveta was founded in 1918. It employs 11 to 50 people.

Where is Bioveta based?

Bioveta is headquartered in Ivanovice Na Hané, Czechia, in the Europe region.

How does Bioveta make money?

One revenue line is on record: veterinary Pharmaceuticals.

Who are Bioveta's main competitors?

Broad incumbents on record are Elanco Animal Health, MSD Animal Health, Zoetis and Boehringer Ingelheim Animal Health. Direct peers are Phibro Animal Health, IDT Biologika, Virbac, Vetoquinol, Huvepharma and Ceva Santé Animale.

Does Bioveta have an API?

No public API is recorded for Bioveta.

What industry is Bioveta in?

Bioveta's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAL, Veterinary Vaccines (Biologics), with a secondary code of HLAMAEAB, Livestock & Production Animal Therapeutics (Rx). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals